Enhanced expression of urokinase receptor induced through the tissue factor-factor VIIa pathway in human pancreatic cancer

Cancer Research

Volumn 58, Issue 19, 1998, Pages 4461-4467

  Taniguchi, Tadaaki ^a   Kakkar, Ajay K ^a   Tuddenham, Edward G D ^a   Williamson, Robin C N ^a   Lemoine, Nicholas R ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR; THROMBOPLASTIN; UROKINASE RECEPTOR;

ARTICLE; BLOOD CLOTTING; CANCER INVASION; HUMAN; HUMAN CELL; METASTASIS; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BREAST NEOPLASMS; CELL MOVEMENT; FACTOR VIIA; FACTOR XA; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PANCREATIC NEOPLASMS; RECEPTORS, CELL SURFACE; THROMBOPLASTIN; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; UP-REGULATION; URINARY PLASMINOGEN ACTIVATOR;

EID: 0032188909     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Mueller, B. M., Reisfeld, R. A., Edgington, T. S., and Ruf, W. Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. Proc. Natl. Acad. Sci. USA, 89: 11832-11836, 1992.
2. Bromberg, M. E., Konigsberg, W. H., Madison, J. F., Pawashe, A., and Garen, A. Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc. Natl. Acad. Sci. USA. 92: 8205-8209, 1995.
3. Kataoka, H., Uchino, H., Asada, Y., Hatakeyama, K., Nabeshima, K., Sumiyoshi, A., and Koono, M. Analysis of tissue factor pathway inhibitor expression in human colorectal carcinoma cell lines and metastatic sublines to the liver. Int. J. Cancer, 72: 878-884, 1997.
4. Bazan, J. F. Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl. Acad. Sci. USA, 87: 6934-6938, 1990.
5. Ruf, W., Schullek, J. R., Stone, M. J., and Edgington, T. S. Mutational mapping of functional residues in tissue factor: identification of factor VII recognition determinants in both structural modules of the predicted cytokine receptor homology domain. Biochemistry, 33: 1565-1572, 1994.
6. Zioncheck, T. F., Roy, S., and Vehar, G. A. The cytoplasmic domain of tissue factor is phosphorylated by a protein kinase C-dependent mechanism. J. Biol. Chem., 267: 3561-3564, 1992.
7. 2+ signals in J82 cells, transfected COS-1 cells Madin-Darby Canine Kidney Cells and in human endothelial cells induced to synthesize tissue factor. J. Biol. Chem., 270: 4650-4660, 1995.
8. Kariko, K., Kuo, A., Boyd, D., Okada, S. S., Cines, D. B., and Barnathan, E. S. Overexpression of urokinase receptor increases matrix invasion without altering cell migration in a human osteosarcoma cell line. Cancer Res., 53: 3109-3117, 1993.
9. Hudson, M. A., and McReynolds, L. M. Urokinase and the urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines. J. Natl. Cancer Inst., 89: 709-717, 1997.
10. Dang, J., Wang, Y., and Doe, W. F. Sodium butyrate inhibits expression of urokinase and its receptor mRNAs at both transcription and post-transcription levels in colon cancer cells. FEBS Lett., 359: 147-150, 1995.
11. Lund, L. R. Expression of urokinase-type plasminogen activator, its receptor and type-1 plasminogen activator inhibitor is differently regulated by inhibitors of protein synthesis in human cancer cell lines. FEBS Lett., 383: 139-144, 1996.
12. Antalis, T. M., and Reeder, J. A. Butyrate regulates gene expression of the plasminogen activating system in colon cancer cells. Int. J. Cancer, 62: 619-626, 1995.
13. Sørensen, B. B., Persson, E., Freskgård, P-O., Kjaika, M., Ezban, M., Williams, T., and Rao, L. V. M. Incorporation of active site inhibitor in factor VIIa alters the affinity for tissue factor. J. Biol. Chem., 272: 11863-11868, 1997.
14. Ruf, W., Rehemtulla, A., and Edgington, T. S. Antibody mapping of tissue factor implicates two different exon-encoded regions in function. Biochem. J., 278: 729-733, 1991.
15. Fischer, E. G., Ruf, W., and Mueller, B. M. Tissue factor-initiated thrombin generation activates the signaling thrombin receptor on malignant melanoma cells. Cancer Res., 55: 1629-1632, 1995.
16. Pendurthi, U. R., Alok, D., and Rao, L. V. M. Binding of factor VIIa to tissue factor induces alterations in gene expression in human fibroblast cells: up-regulation of poly(A) polymerase. Proc. Natl. Acad. Sci. USA, 94: 12598-12603, 1997.
17. Poulsen, L. K., Jacvobsen, N., Sorenson, B. B., Bergenhem, N. C. H., Kelly, J. D., Foster, D. C., Thastrup, O., Ezban, M., Petersen, L. C. Signal transduction via the mitogen-activated protein kinase pathway induced by binding of coagulation factor VIIa to tissue factor. J. Biol. Chem., 273: 6228-6232, 1998.
18. Ploug, M., Ronne, E. N., Jensen, A. L., Blasi, F., and Dano, K. Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol. J. Biol. Chem., 260: 1926-1933, 1991.
19. Moller, L. B., Ploug, M., and Blasi, F. Structural requirements for glycosyl-phosphatidylinositol-anchor attachment in the cellular receptor for urokinase plasminogen activator. Eur. J. Biochem., 208: 493-500, 1992.
20. Lau, H. K., and Kim, M. Soluble urokinase receptor from fibrosarcoma HT-1080 cells. Blood Coagul. Fibrinolysis, 5: 473-478, 1994.
21. Pedersen, N., Schmitt, M., Ronne, E., Nicoletti, M. I., Hoyer-Hansen G., Conese, M., Giavazzi, R., Dano, K., Kuhn, W., Janicke, F., and Blasi, F. A ligand-free, soluble urokinase receptor is present in the ascitic fluid from patients with ovarian cancer. J. Clin. Invest., 92: 2160-2167, 1993.
22. Odekon, L. E., Blasi, F., and Rifkin, D. B. Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-β to TGF-β. J. Cell. Physiol., 158: 398-407, 1994.
23. Okada, S., Tomaszewski, J. E., and Barnathan, E. S. Migrating vascular smooth muscle cells polarize cell surface urokinase receptors after injury in vitro. Exp. Cell Res., 217: 180-187, 1995.
24. Nip, J., Rabbani, S. A., Shibata, H. R., and Brodt, P. Co-ordinated expression of the vitronectin receptor and the urokinase-type plasminogen activator receptor in metastatic melanoma cells. J. Clin. Invest., 95: 2096-2103, 1995.
25. Xue, W., Mizukami, I., Todd, R. F., III, Petty, H. R. Urokinase-type plasminogen activator receptors associate with β-1 and β-3 integrins of fibrosarcoma cells: dependence on extracellular matrix components. Cancer Res., 57: 1682-1689, 1997.
26. Carriere, M. V., Del Vecchio, S., Franco, P., Potena, M. I., Chiaradonna, F., Botti, G., Stoppelli, M. P., and Salvatore, M. Vitronectin binding to urokinase receptor in human breast cancer. Clin. Cancer Res., 3: 1299-1308, 1997.
27. Cantero, D., Friess, H., Deflorin, J., Zimmermann, A., Brundler, M. A., Riesle, E., Korc, M., and Buchler, M. W. Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma. Br. J. Cancer, 75: 388-395, 1997.
28. Duggan, C., Maguire, T., McDermott, E., O'Higgins, N., Fennelly, J. J., and Duffy, M. J. Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer. Int. J. Cancer, 61: 597-600, 1995.
29. Pyke, C., Kristensen, P., Ralfkiaer, E., Grondahl-Hansen J., Eriksen, J., Blasi, F., and Dano, K. Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. Am. J. Pathol., 138: 1059-1067, 1991.
30. Schmalfeldt, B., Kuhn, W., Reuning, U., Fache, L., Dettmar, P., Schmitt, M., Janicke, F., Hofler, H., and Graeff, H. Primary tumor and metastasis in ovarian cancer differ in their content of urokinase-type plasminogen activator, its receptor, and inhibitors types 1 and 2. Cancer Res., 55: 3958-3963, 1995.
31. Shetty, S., Kumar, A., and Idell, S. Posttranscriptional regulation of urokinase receptor mRNA: identification of a novel urokinase receptor mRNA binding protein in human mesothelioma cells. Mol. Cell. Biol., 17: 1075-1083, 1997.
32. Pepper, M. S., Sappino, A-P., Stocklin, R., Montesano, R., Orci, L., and Vassalli, J.D. Upregulation of urokinase receptor expression on migrating endothelial cells. J. Cell Biol., 122: 673-684, 1993.
33. Carmeliet, P., Mackman, N., Moons, L., Luther, T., Gressens, P., Vlaenderen, I. V., Demunck, H., Kasper, M., Breier, G., Evrard, P., Muller, M., Risau, W., Edgington, T., and Collen, D. Role of tissue factor in embryonic blood vessel development. Nature (Lond.), 383: 73-75, 1996.
34. Rosen, E. D., Chan, J. C. Y., Idusogie, E., Clotman, F., Vlasuk, G., Luther, T., Jalbert, L. R., Albrecht, S., Zhong, L., Lissens, A., Schoonjans, L., Moons, L., Collen, D., Castellino, F. J., and Carmeliet, P. Mice lacking factor VII develop normally but suffer fatal perinatal bleeding. Nature (Lond.), 390: 290-294, 1997.
35. Kakkar, A. K., Lemoine, N. R., Scully, M. F., Tebbutt, S., and Williamson, R. C. N. Tissue factor expression correlates with histological grade in human pancreatic cancer. Br. J. Surg., 82: 1101-1104, 1995.
36. Kakkar, A. K., DeRuvo, N., Chinswangwatanakul, V., Tebbutt, S., and Williamson, R. C. N. Extrinsic-pathway activation in cancer with high factor VIIa and tissue factor. Lancet, 346: 1004-1005, 1995.
37. Huang, X., Molema, G., King, S., Watkins, L., Edgington, T. S., and Thorpe, P. E. Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature. Science (Washington DC), 275: 547-550, 1997.